Home > News Shots > India

By Vinershea | Jul 17, 2020 03:58 PM

As the novel coronavirus continues to spread around the world, India came up with a breakthrough update on the deadly vaccine. 

coronavirus vaccine covaxin bharat biotech human trial successful

Haryana health minister Anil Vij took to his social media account and announced that clinical trials to fight Covid-19 with Covaxin have started at Post Graduate Institute of Medical Sciences (PGIMS) in Rohtak. This will be the country’s foremost vaccine candidate for Covid-19. 

“Three subjects were enrolled for this purpose today (Friday). All three have tolerated the vaccine very well. There were no adverse effects,” he tweeted in his post.

According to a Hindustan Times report, 10 days since PGIMS began enrolling subjects for clinical trials of Covaxin and close to 100 individuals from Haryana have registered to be a part of the study.  

Meanwhile, officials at PGIMS Rohtak state that, said that "22 of these volunteers have already been screened for their medical history, and that at least three of them will receive a dose of the experimental vaccine by the weekend or early next week."

"This Covaxin is an indigenous Covid-19 vaccine, which is being developed by Bharat Biotech and the ICMR’s National Institute of Virology, Pune. It is one of the two Indian vaccine candidates that have received the Drug Controller General of India’s nod to proceed with the Phase 1 and Phase 2 human clinical trials. In Rohtak, the sample size for Phase 1 trials is expected to around 8 to 10 people," officials said.

Dr Dhruv Chaudhary, who is a part of a three-member team leading the clinical trials at PGIMS, Rohtak, asserted that, “the first batch of volunteers have been screened. Eight individuals have undergone rigorous medical scrutiny to check whether or not they have been previously infected with the virus, whether they suffer from any ailments of the liver, lungs, or kidneys, and to check if they have any history of other infectious diseases."

"Three of these volunteers, who were found eligible, will receive a dose of the vaccine, possibly by the weekend. Another 14 people were screened on Thursday and their biochemical reports are awaited," he later added.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      



This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. Coronavirus vaccine covaxin bharat biotech human trial successful | India News.